Metraipolis › archive › dc_d1bfe89ea5a2

Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy — Europe PMC PMID:40940612

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940612
DOI
10.1002/advs.202510004
License (as archived)
solo-consultazione
Archived
2026-11-09T23:51:24.300Z
SHA-256 of the archived text
96679dec1dc04b97ca6b359d4b37d9c225ac43fcc88389e1730a3222698e66d1
Stable URL of this page
https://metraipolis.com/documento/dc_d1bfe89ea5a2

How to cite

Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy — Europe PMC PMID:40940612 — Europe PMC (en), https://europepmc.org/article/MED/40940612 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1bfe89ea5a2 (Metraipolis archive dc_d1bfe89ea5a2, sha256 96679dec1dc04b97ca6b359d4b37d9c225ac43fcc88389e1730a3222698e66d1)
BibTeX
@misc{dcd1bfe89ea5a2,
  title = {Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy — Europe PMC PMID:40940612},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940612},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1bfe89ea5a2; sha256 96679dec1dc04b97ca6b359d4b37d9c225ac43fcc88389e1730a3222698e66d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940612. Agents can read the archived copy with the MCP tool read_document.